Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,830.00
Bid: 1,828.00
Ask: 1,834.00
Change: 32.00 (1.78%)
Spread: 6.00 (0.328%)
Open: 1,794.00
High: 1,834.00
Low: 1,794.00
Prev. Close: 1,798.00
RCP Live PriceLast checked at -
RIT Capital Partners is an Investment Trust

To invest in a widely diversified, international portfolio across a range of asset classes, both quoted and unquoted; to allocate part of the portfolio to exceptional managers in order to ensure access to the best external talent available.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

14 Oct 2022 07:00

RNS Number : 8548C
RIT Capital Partners PLC
14 October 2022
 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

14 October 2022

 

30 September 2022 Net Asset Value and Commentary

The unaudited diluted net asset value of RIT Capital Partners plc as at 30 September 2022 (with debt at fair value) was 2,464p per £1 ordinary share (31 August 2022: 2,523p).

In light of the extraordinary market conditions experienced during late September, we felt it would be helpful for shareholders if we provided some more colour on the behaviour of our portfolio during times like these, as well as putting it into the context of our long-term objectives.

September saw equity markets fall sharply. The FTSE 250 lost -9.7%, the S&P 500 -9.2% and our own reference index, the MSCI All Countries World Index (50% Sterling) was down -7.1%. The exceptional volatility was not limited to equity markets, with all asset classes experiencing wide swings notably across currencies, bond markets and commodities. Against this most challenging backdrop, our NAV total return over the month was a decline of -2.3%. This outperformance reflected in particular:

· Our cautious positioning, with historically low levels of quoted equity exposure, helped to protect us from the brunt of the stock market falls;

· Positive contribution from our currency positioning, with around half our portfolio held outside of Sterling benefiting the NAV as Sterling weakened; and

· Some modest give back of the exceptional gains from our private investments over recent years. 

Our year-to-date NAV total return therefore shows a decline of -11.2% against the ACWI which lost -16.0%, with the outperformance reflecting broadly the same drivers as above. With a corporate objective focused on the long-term, our three-year performance of 31.9% compares favourably with the ACWI of 17.9% as does our five-year performance of 47.9% compared to 37.1% for global equities. This performance also exhibited lower risk, whether measured by volatility or the size of any drawdowns.

Our private investments have been a key source of returns over RIT's history and in particular during recent years. While we have seen some value compression this year, underlying portfolio companies continue to perform well and we remain confident in their ability to generate future NAV performance. Our direct private investments are valued on a six-monthly cycle by our independent Valuation Committee, and the private funds report quarterly fair values, on a lagged basis as is standard for this industry. By the end of September, the vast majority of our funds (around 99%) were valued at 30 June quarterly valuations. 

As shareholders are aware, the nature and composition of our investment portfolio enables us to produce monthly rather than daily NAVs. At times of significant market stress, the wider market conditions can dominate such that our share price moves in sync with broad equity markets, irrespective of our underlying NAV. This may lead to a widening of the discount. In these circumstances, we have continued our approach of seeking to minimise the impact on shareholders by buying back shares accretively. During September we acquired some 280,000 shares at a cost of around £6.1m, increasing the NAV per share. 

Shareholders will also be aware that our share price became ex-dividend on 6 October and we will pay our second interim dividend of 18.5p per share on 28 October. This will provide shareholders with a total dividend of 37p for 2022, 5.0% above 2021.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVEXLFFLBLEFBK
Date   Source Headline
16th Dec 20197:00 amRNSNet Asset Value(s)
4th Dec 20195:02 pmRNSComposition of Board Committee
15th Nov 20197:00 amRNSNet Asset Value(s)
22nd Oct 20195:10 pmRNSHolding(s) in Company
14th Oct 20197:00 amRNSNet Asset Value(s)
3rd Oct 20193:17 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Sep 201912:18 pmRNSCorrection
16th Sep 20197:00 amRNSNet Asset Value(s)
14th Aug 20197:00 amRNSNet Asset Value(s)
5th Aug 20197:00 amRNSHalf-year Report
17th Jul 20197:00 amRNSNet Asset Value(s)
3rd Jul 20192:42 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
18th Jun 20195:04 pmRNSDirector/PDMR Shareholding
17th Jun 20194:20 pmRNSHolding(s) in Company
14th Jun 20197:00 amRNSNet Asset Value(s)
15th May 20197:00 amRNSNet Asset Value(s)
12th Apr 20197:00 amRNSNet Asset Value(s)
3rd Apr 20193:59 pmRNSQUARTERLY DISCLOSURE - Listing Rule 15.6.8
22nd Mar 20194:01 pmRNSDirector/PDMR Shareholding
14th Mar 20197:00 amRNSNet Asset Value(s)
5th Mar 20197:00 amRNSAnnual Financial Report
18th Feb 20197:00 amRNSNet Asset Value(s)
5th Feb 20197:00 amRNSNet Asset Value(s)
8th Jan 201910:02 amRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Dec 20187:00 amRNSNet Asset Value(s)
30th Nov 201810:53 amRNSComposition of Board Committee
14th Nov 20187:00 amRNSNet Asset Value(s)
29th Oct 20184:59 pmRNSComposition of Board Committee
16th Oct 201811:11 amRNSDirector Declaration
12th Oct 20187:00 amRNSNet Asset Value(s)
5th Oct 20185:03 pmRNSDirector/PDMR Shareholding
4th Oct 20185:46 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Sep 20187:00 amRNSNet Asset Value(s)
24th Aug 20183:15 pmRNSAppointment of Joint Broker
14th Aug 20187:00 amRNSNet Asset Value(s)
7th Aug 20187:00 amRNSHalf-year Report
18th Jul 20187:00 amRNSNet Asset Value(s)
3rd Jul 20186:00 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Jun 20187:00 amRNSNet Asset Value(s)
15th May 20187:00 amRNSNet Asset Value(s)
26th Apr 201812:41 pmRNSDirectorate Change
26th Apr 201812:27 pmRNSResult of AGM
16th Apr 20187:25 amRNSNet Asset Value(s)
6th Apr 20185:54 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
28th Mar 20185:09 pmRNSDirector/PDMR Shareholding
26th Mar 201811:54 amRNSDirectorate Change
14th Mar 20187:00 amRNSNet Asset Value(s)
5th Mar 20186:00 pmRNSDirector/PDMR Shareholding
27th Feb 20187:00 amRNSFinal Results and Dividend
14th Feb 20187:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.